Different studies have reported a significant increase of CXCL8 during ALS development and progression, both at systemic (e.g., blood, serum) and central (CSF or spinal cord tissue) levels [19,20,21,22,23,24,25,26]. The gene discussed is CXCL8; the disease is amyotrophic lateral sclerosis.